Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alpine Immune Sciences Inc (NASDAQ:ALPN)

11.19
Delayed Data
As of Dec 14
 +0.01 / +0.09%
Today’s Change
7.20
Today|||52-Week Range
14.52
+24.89%
Year-to-Date
No recent news for Alpine Immune Sciences Inc.

Today’s Trading

Previous close11.18
Today’s open11.28
Day’s range10.99 - 11.39
Volume9,451
Average volume (3 months)36,344
Market cap$155.2M
Data as of 4:00pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)+16.42%
Earnings growth (this year)+85.71%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.78

Competitors

 Today’s
change
Today’s
% change
NVIVInVivo Therapeutics ...-0.05-5.53%
CLBSCaladrius Bioscience...-0.02-0.58%
MTEMMolecular Templates ...+0.04+0.56%
CSBRChampions Oncology I...-0.17-4.09%
Data as of 4:00pm ET, 12/14/2017

Financials

Next reporting dateMarch 5, 2018
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$0.00
Annual profit (last year)-$31.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Mitchell H. Gold
President &
Director
Jay Venkatesan
Corporate headquarters
Seattle, Washington

Forecasts